A federal judge in Los Angeles on Thursday dismissed a class actionlawsuit against Amgen Inc. that alleged securities laws violations bythe Thousand Oaks, Calif., company and two of its senior officers.The suit was filed in February after a decline in Amgen's stock price,which resulted from an announcement by Amgen that sales ofNeupogen in the first quarter of the year would likely be lower thananalysts' expectations. No payment or settlement was made by Amgenin return for the dismissal.The judge entered the order at the request of Amgen and the plaintiffs'attorneys, who decided pursuit of the case would be fruitless. _ JimShrine
(c) 1997 American Health Consultants. All rights reserved.